Changyao Group(SZ:300391) Zhi Tong Cai Jing·2026-01-13 11:56Core Viewpoint - *ST长药 is facing potential delisting due to its stock price and market capitalization falling below regulatory thresholds, with significant financial distress indicated by negative net assets expected for the fiscal year 2025 [1] Group 1: Stock Performance - As of January 13, 2026, the company's stock closed at 0.79 yuan per share, remaining below 1 yuan for nine consecutive trading days [1] - The company's market capitalization is reported at 2.77 billion yuan, having been below 3 billion yuan for three consecutive trading days [1] Group 2: Regulatory Compliance - According to the Shenzhen Stock Exchange's rules, if the stock price remains below 1 yuan or the market capitalization below 3 billion yuan for twenty consecutive trading days, the stock will be delisted [1] - The company has been under delisting risk warnings since April 22, 2025, and has faced additional warnings since December 29, 2025 [1] Group 3: Financial Condition - The company is expected to report negative net assets for the fiscal year ending December 31, 2025, pending the final audited financial report [1] - If the audited net assets are negative or if the financial report receives a qualified, adverse, or disclaimer opinion, the company will trigger mandatory delisting conditions [1]